Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q2 2015 · 10-Q
Revenue$111.95M$111.95M+33.2% vs Q2 2014 Net Income$33.21M$33.21M+32.5% vs Q2 2014 EPS Diluted$0.89$0.89+30.9% vs Q2 2014 Gross Profit$75,743,000+29.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Cash Flowderived$35,726,000+14.1% Free Cash Flowderived$32,584,000+17.7% Margins · derivedGross margin67.7%−2.1 pt vs Q2 2014
Operating margin30.9%−11.7 pt vs Q2 2014
Net margin29.7%−0.2 pt vs Q2 2014
ended Dec 31, 2014 · filed Feb 9, 2015 · 40 d after period end